PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
16-Aug-2024 Compounding Pharmacies Market on the Rise: Estimated Value to Hit USD 20.2 Billion by 2032 Global Market Insights, Inc.
15-Aug-2024 AsiaMedic continues growth streak with 23% increase in revenue for First Half ended 30 June 2024 AsiaMedic Limited
14-Aug-2024 OrganaBio Manufactures First GMP Cryopreserved Leukopaks for Two New Biopharma Partners’ Allogeneic Cell Therapies OrganaBio
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer SpyBiotech
14-Aug-2024 Breakthrough heart MRI technique accurately predicts heart failure risk in general population The University of East Anglia (UEA)
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026 Santhera Pharmaceuticals
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
14-Aug-2024 NHS requires compliance with BSI Kitemark™ to promote responsible antibiotic manufacturing BSI
14-Aug-2024 Fewer Brits think people from different backgrounds get on and under 50% satisfied with healthcare London Medical Laboratory
13-Aug-2024 Venistro Biotech Highlights Key Trends Shaping the PCD Pharma Franchise Market for 2025-2032 Venistro Biotech
13-Aug-2024 InnoScot Health calls on Scotland to embrace learnings to capitalise upon £80bn research, development and innovation programme InnoScot Health
13-Aug-2024 What to Look for in a Trusted Itraconazole Capsules Manufacturer: Insights from Leading Pharma Manufacturer DM Pharma DM Pharma Private Limited
12-Aug-2024 Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year Q&M Dental Group Ltd
12-Aug-2024 Antibody Therapy Market Is Likely to Experience a Tremendous Growth in Near Future Acumen Research and Consulting
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma
09-Aug-2024 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis Levicept
07-Aug-2024 XF-73 treatment of MRSA burn wound infection prevents bacterial invasion of the bloodstream Destiny Pharma plc
07-Aug-2024 New results from AlzeCure's pain project TrkA-NAM presented at the pain conference IASP 2024 AlzeCure Pharma AB